- 3 'Clear Sailing' Mid-Caps For Investors: Strategist
- Expect Stocks to End the Year Lower: Market Pro
- Wal-Mart To Continue Retail Success: Analysts
- Opposing Views on Coca-Cola Price Target
- How To Play China's 'Amazing' Run: Analysts
- Commercial Real Estate Best Place For Money: Strategist
- Enterprise Tech Companies to Focus On: Portfolio Manager
- This Chemical Company Will Rally into 2010: Trader
- 3 Safe Investments That Let You ‘Sleep Better:’ Strategist
- Beware of 'Trampling Effect' When Market Tops: Manager
MOST SHARED
- Hewlett-Packard to Acquire 3Com for $2.7 Billion in Cash
- How the Droid and Google Threaten the GPS Makers
- Dollar Trouble, Oil's Bubble Could Derail Recovery
- CNN Anchor Lou Dobbs Says He is Leaving Network
- USC Football Blog Leads All-Access Space
- Shopping for Answers
- HPQ to Acquire 3Com
- Rising Jobless Biggest Threat to World Trade: WTO
- APEC Pledges to Back 'Market-Oriented' Currencies
- Pricier Beer Helps AB InBev Operating Profit
- What to Expect From Disney Earnings?
- HP's Shot Across Cisco's Bow
- USC Football Blog Leads All-Access Space
- Clowning Around At Work
- Ahead of Earnings Disney Restructures Studio
- Nov. 11: Unusual Volume Leaders
- 3 'Clear Sailing' Mid-Caps For Investors: Strategist
- Intimate Apparel Sales Heating Up: Maidenform CEO
- A Day On The USS Harry S. Truman
- US Mortgage Refinancing Up; Buying Demand Sinks
- Rising Jobless Biggest Threat to World Trade: WTO
- Gold Hits $1,122, Barrick Chief Says Selloff Possible
- Wall Street Pay Is Often too High: Bill Gates
- Morgan Stanley Gets Aggressive in Luring Brokers
- Foreclosures Fall Again But Improvement Likely Fleeting
- Highest State Foreclosure Rates
- Yuan Critics Want Obama to Keep Campaign Promise
- Obama Most Powerful Person in World: Forbes
RSS FEED
CNBC Stock Blog
Size doesn't necessarily matter when it comes to five-star investing. Just ask Frank Sustersic, portfolio manager for Turner Investment Partners.
His small-cap Turner Emerging Growth Fund is up an average of 16.40 percent per year over the last five years. It's currently closed to new investors, but Sustersic is willing to share some of his favorite names.
Recommendations:
Some of his favorite stocks are clinical-research organizations, or CROs.
"They help pharmaceutical companies conduct clinical-research trials," he told CNBC. "All of the companies right now have an amazing tailwind...and currently, there is a pretty significant outsourcing trend that's occurring; pharmaceutical and biotech companies are trying to change their cost structure to be more flexible."
Two of those CROs are Parexel
[PRXL
Loading...
()
] and Icon
[ICLR
Loading...
()
].
"Over the next three to six months, the stocks could need to consolidate a bit," he cautioned, but added, "Over the long-term period of time, I'm still optimistic about these stocks."
Sustersic also likes Ansys
[ANSS
Loading...
()
].
"Ansys makes (simulation) software used by engineers in product designs," he said. "They have a subscription model, so about 70 percent of their revenue base is recurring via subscription or licensing and maintenance."
(Contd.)
____________________________________
CNBC Stock Intelligence:
____________________________________
He's also enthusiastic about Willbros Group
[WG
Loading...
()
], a producer of large-diameter pipeline for natural-gas and oil companies.
"They recently got some big contract wins up in Canada," he noted. "They're probably sold out for the next year or so."
Rounding out his list -- and maybe, saving the best for last -- is Deckers Outdoor
[DECK
Loading...
()
], maker of the popular UGG brand boots.
"Very controversial, very volatile stock," he said, "It still looks like fantastic visibility going forward."
He said an informal survey of department-store buyers revealed that UGGs was the only apparel or shoe product that really sold well during the last holiday-shopping season.
"If anything, they regretted not ordering more," he said.
Disclosures:
Disclosure information for Frank Sustersic was not immediately available.









